The trademark application Bemrelfy was filed by Novo Nordisk A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on March 8, 2022, and it was registered by office on June 15, 2022 without any oppositions.
The application was filed in Danish (English was selected as the second language).